Explore more publications!

Anguilla Business Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Business Daily.

Press releases published on December 10, 2025

CEDARst and Kayne Anderson Expand Chicago Multifamily Portfolio With Acquisition of 47-Story Residential Tower
Statement from Beneficient Regarding the Passing of Thomas O. Hicks
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Transcontinental Inc. Announces Results for the Fourth Quarter and Fiscal Year 2025
Transcontinental inc. annonce ses résultats du quatrième trimestre et de l'exercice financier 2025
Univest Securities, LLC Announces Closing of $5.04 Million Public Offering for Its Client Top Wealth Group Holding Limited (NASDAQ: TWG)
Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026
SPAR Group, Inc. Appoints Steven Hennen as New Chief Financial Officer
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Premium Brands Holdings Corporation Announces the Acquisition of Stampede Culinary Partners and Concurrent Equity and Convertible Debenture Offerings
Bakkt Files Post-Effective Amendments to Form S-3 Registration Statements Following Corporate Reorganization
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4)
ABITS Group maintains growth momentum in its third quarter of 2025
Host Hotels & Resorts Announces Fourth Quarter 2025 Earnings Call to be Held on February 19, 2026
Canoe EIT Income Fund Announces 2025 Annual Redemption Price
Le fonds de revenu Canoe EIT annonce son prix de rachat annuel pour 2025
Daedalus Special Acquisition Corp. Announces Closing of Upsized $250 Million Initial Public Offering
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions